Completed PHASE2 INTERVENTIONAL 2-arm
NCT07418918
Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb) (BV)
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study on the Efficacy and Safety of Lactobacillus Bicomponent Viable Capsules for Vaginal Use in the Treatment of Bacterial Vaginosis
Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd.
Conditions
Bacterial Vaginosis
Interventions
Placebo Vaginal Lactobacillus Dual Probiotic Capsules
Updated 1 time since 2026 Last updated: Feb 11, 2026 Started: Jan 3, 2023 Primary completion: Sep 1, 2023 Completion: Nov 11, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07418918, this PHASE2 trial focuses on Bacterial Vaginosis and remains completed. Sponsored by Guangdong Longchuangji Pharmaceutical Co., Ltd., it has been updated 1 time since 2023, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
1 version recorded Completed — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Guangdong Longchuangji Pharmaceutical Co., Ltd.
Data source: Guangdong Longchuangji Pharmaceutical Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .